Barbara Oil Co. purchased a new position in Baxter International Inc. (NYSE:BAX - Free Report) in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm purchased 40,000 shares of the medical instruments supplier's stock, valued at approximately $853,000.
Several other hedge funds also recently made changes to their positions in BAX. Pzena Investment Management LLC bought a new position in Baxter International in the 2nd quarter worth about $1,392,098,000. Tocqueville Asset Management L.P. purchased a new position in Baxter International during the 2nd quarter valued at about $30,604,000. AMG National Trust Bank bought a new stake in shares of Baxter International during the second quarter valued at about $2,522,000. BlackRock Inc. bought a new stake in shares of Baxter International during the second quarter valued at about $1,744,874,000. Finally, Edmond DE Rothschild Holding S.A. purchased a new stake in shares of Baxter International in the second quarter worth about $51,958,000. 90.19% of the stock is currently owned by hedge funds and other institutional investors.
Wall Street Analyst Weigh In
A number of equities analysts have recently commented on the stock. UBS Group raised their price objective on shares of Baxter International from $19.00 to $25.00 and gave the company a "hold" rating in a research report on Tuesday, July 28th. Wall Street Zen raised shares of Baxter International from a "hold" rating to a "buy" rating in a report on Saturday, August 1st. Barclays increased their target price on shares of Baxter International from $25.00 to $27.00 and gave the stock an "overweight" rating in a research note on Friday, May 1st. Citigroup raised shares of Baxter International from a "sell" rating to a "neutral" rating and raised their price target for the company from $17.00 to $28.00 in a report on Friday, July 31st. Finally, TD Cowen boosted their price target on shares of Baxter International from $20.00 to $24.00 and gave the company a "hold" rating in a research report on Monday, July 27th. Two research analysts have rated the stock with a Buy rating, nine have issued a Hold rating and two have issued a Sell rating to the stock. According to MarketBeat, the company currently has a consensus rating of "Hold" and an average target price of $22.45.
Read Our Latest Analysis on BAX
Baxter International Stock Performance
Shares of BAX opened at $26.37 on Monday. The company has a market cap of $13.63 billion, a PE ratio of -12.74, a price-to-earnings-growth ratio of 3.99 and a beta of 0.59. The company has a current ratio of 1.95, a quick ratio of 1.32 and a debt-to-equity ratio of 1.39. The stock has a 50-day moving average price of $23.62 and a 200-day moving average price of $20.36. Baxter International Inc. has a 12-month low of $15.73 and a 12-month high of $30.00.
Baxter International (NYSE:BAX - Get Free Report) last posted its quarterly earnings data on Thursday, July 30th. The medical instruments supplier reported $0.56 earnings per share for the quarter, topping the consensus estimate of $0.37 by $0.19. The company had revenue of $2.96 billion for the quarter, compared to analysts' expectations of $2.80 billion. Baxter International had a negative net margin of 9.27% and a positive return on equity of 16.57%. Baxter International's revenue for the quarter was up 5.3% compared to the same quarter last year. During the same period in the prior year, the business earned $0.59 earnings per share. Baxter International has set its FY 2026 guidance at 1.950-2.150 EPS. As a group, equities analysts forecast that Baxter International Inc. will post 2.04 earnings per share for the current fiscal year.
Baxter International Dividend Announcement
The business also recently declared a quarterly dividend, which will be paid on Thursday, October 1st. Stockholders of record on Friday, August 28th will be issued a $0.01 dividend. The ex-dividend date of this dividend is Friday, August 28th. This represents a $0.04 dividend on an annualized basis and a dividend yield of 0.2%. Baxter International's dividend payout ratio is presently -1.93%.
Baxter International Profile
(
Free Report)
Baxter International Inc is a global healthcare company that develops, manufactures and markets a broad portfolio of medical products, pharmaceutical therapies and biotechnology-based solutions. The company's primary business activities are organized around renal care, medication delivery, acute therapies, pharmacy automation, surgical care and biotechnology. Baxter's offerings are designed to support patient care in hospitals, dialysis centers, nursing homes and other healthcare facilities worldwide.
In the renal care segment, Baxter provides hemodialysis and peritoneal dialysis systems, water treatment equipment and related disposables, including dialyzers, bloodlines and catheters.
Read More
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Baxter International, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Baxter International wasn't on the list.
While Baxter International currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link to see MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
